TABLE 8.
Serum lipid parameter of hyperlipidemic volunteers at baseline, day 30, and day 60 during phase 2 (mean ± SD).
Control | 250 mg OPP | |
---|---|---|
Total cholesterol (mmol/L) | ||
Day 1 | 5.78 ± 0.52 | 5.76 ± 0.54 |
Day 30 | 5.56 ± 0.66a | 5.54 ± 0.68a |
Day 60 | 5.51 ± 0.49a | 5.49 ± 0.67a |
HDL (mmol/L) | ||
Day 1 | 1.30 ± 0.25 | 1.37 ± 0.34 |
Day 30 | 1.26 ± 0.23 | 1.40 ± 0.34 |
Day 60 | 1.34 ± 0.24c | 1.42 ± 0.34 |
LDL (mmol/L) | ||
Day 1 | 3.88 ± 0.51 | 3.82 ± 0.59 |
Day 30 | 3.67 ± 0.62a | 3.59 ± 0.63a |
Day 60 | 3.51 ± 0.60b | 3.53 ± 0.69a |
Triglycerides (mmol/L) | ||
Day 1 | 1.30 ± 0.82 | 1.25 ± 0.54 |
Day 30 | 1.38 ± 0.62 | 1.23 ± 0.55 |
Day 60 | 1.46 ± 0.90 | 1.16 ± 0.46 |
Abbreviation: TC, total cholesterol; TG, triglycerides; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
aSignificantly different compared to day 1 within the group (p < 0.05).
bSignificantly different compared to day 1 within the group (p < 0.001).
cSignificantly different compared to day 30 within the group (p < 0.05).